Feb 24 2017 |
Fourth Circuit Leaves Undisturbed a District Court Decision Against the Use of Statistical Sampling, and Holds that the United States Has the Unfettered Power to Veto FCA Settlements |
Faegre Drinker |
Feb 23 2017 |
2017 Health Care Policy Debates Ramp Up in Massachusetts |
Mintz |
Feb 23 2017 |
Justice Department Joins Whistleblower Suit Accusing UnitedHealth Group of Overcharging Medicare by “Hundreds of Millions” |
Sheppard, Mullin, Richter & Hampton LLP |
Feb 22 2017 |
Florida Supreme Court Rules That Hospital "Adverse Medical Incidents" Reported to a PSO Are Not Privileged From Discovery: Impact on Participating Providers and PSOs |
Katten |
Feb 22 2017 |
Costly Failure to Safeguard Protected Health Information from Unauthorized Staff |
Faegre Drinker |
Feb 22 2017 |
Medicaid Reform: It’s All About Paying Providers |
Mintz |
Feb 22 2017 |
Fourth Circuit Permits DOJ to Reject FCA Settlement, But Punts Decision on Statistical Sampling |
Mintz |
Feb 21 2017 |
The 340B Program Omnibus Guidance: Not Ready for Prime Time |
Sheppard, Mullin, Richter & Hampton LLP |
Feb 21 2017 |
Free Or Discounted Local Patient Transportation Given The Green Light By Office of Inspector General In A new Anti-Kickback Statute Safe Harbor |
Godfrey & Kahn S.C. |
Feb 21 2017 |
Change on the Horizon for Decades-Old Home Health Agency Conditions of Participation |
Jackson Lewis P.C. |
Feb 21 2017 |
OIG Publishes Online Portfolio Highlighting its Body of Work on Drug Pricing and Reimbursement |
Mintz |
Feb 21 2017 |
$5.5 Million HIPAA Settlement Underscores Importance of Audit Controls |
Mintz |
Feb 21 2017 |
Top 10 Takeaways from SAMHSA’s Recent Update of Substance Use Disorder Confidentiality Regulations: Substance Abuse and Mental Health Services Administration |
Faegre Drinker |
Feb 21 2017 |
HIPAA Small Breach Notifications Due to OCR March 1 |
von Briesen & Roper, s.c. |
Feb 20 2017 |
Federal Circuit Knocks Out Patents After CMB Challenge |
Foley & Lardner LLP |
Feb 17 2017 |
CDC Issues New Guidance For Use of EPA-Registered Disinfectants in Environmental Control of Candida auris for U.S. Healthcare Facilities |
Bergeson & Campbell, P.C. |
Feb 17 2017 |
FDA Hardens Its Stance on Intended Use and Off-Label Use and Industry Responds |
Mintz |
Feb 17 2017 |
The Future of the Affordable Care Act Week 6: Focus on the Individual Health Insurance Market |
Mintz |
Feb 16 2017 |
Fourth Circuit Punts at Rare Opportunity to Rule on Statistical Sampling |
Sheppard, Mullin, Richter & Hampton LLP |
Feb 15 2017 |
Reference-Based Pricing: Case Study & Discussion [VIDEO] |
K&L Gates LLP |
Feb 15 2017 |
CMS’s Draft 2018 Call Letter: Minor Updates, but Largely Continuation of Current Policies |
Mintz |
Feb 14 2017 |
Will Ninth Circuit Verdict Encourage Counsel To Become Healthcare Relators? |
Squire Patton Boggs (US) LLP |
Feb 14 2017 |
Tenth Circuit Court Agrees Difference Of Opinion On Medical Necessity Is Insufficient to Show Falsity Under False Claims Act |
Mintz |
Feb 14 2017 |
CMS Nominee Seema Verma Visits Senate Finance |
Squire Patton Boggs (US) LLP |
Feb 13 2017 |
Enforcement Status of ACA Section 1557 Regulations |
Morgan, Lewis & Bockius LLP |
Feb 13 2017 |
Affordable Care Act Replacement Bills Encounter Beltway Traffic |
Bracewell LLP |
Feb 13 2017 |
Minimal Fines Little Incentive for Facilities to Improve Patient Care |
Rosenfeld Injury Lawyers |
Feb 11 2017 |
St. Jude Cybersecurity Vulnerability Extended to Provider-Owned Devices |
Mintz |
Feb 11 2017 |
Week Ahead in European Parliament – February 10, 2017: Public Health and Food Safety; CETA; Committee on Legal Affairs |
Covington & Burling LLP |
Feb 10 2017 |
Clinical Research (R)evolution – Updating the “Common Rule” for the Modern Era |
Faegre Drinker |
Feb 10 2017 |
Health Systems Governance: Board Refreshment |
McDermott Will & Emery |
Feb 10 2017 |
340B Drug Pricing Program Omnibus Guidance Withdrawn |
Godfrey & Kahn S.C. |
Feb 10 2017 |
Effective Use of Health System Board Committees |
McDermott Will & Emery |
Feb 10 2017 |
Closer Scrutiny of Nonprofit Health Systems Board Conflicts |
McDermott Will & Emery |
Feb 10 2017 |
The Number One Fiduciary Duty Issue of 2017: Uncertainty |
McDermott Will & Emery |